Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
- Status
- COMPLETED
- Phase
- PHASE3
Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).
- Status
- TERMINATED
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Trial of BMS-986012 in Combination With Platinum and Etoposide
- Status
- COMPLETED
- Phase
- PHASE1
European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Nab-Paclitaxel in Combination With Carboplatin as First-line Therapy in Patients With NSCLC
- Status
- COMPLETED
- Phase
- N/A
Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor
- Status
- UNKNOWN
- Phase
- PHASE2
Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma
- Status
- UNKNOWN
- Phase
- PHASE2
Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma
- Status
- UNKNOWN
- Phase
- PHASE2